Biotech · Private company
pharmaand GmbH
Track this companyFree. Adds pharmaand GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials151 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- Abiraterone acetate or Enzalutamide or DocetaxelPhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- ChemotherapyPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 3 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 3 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Bortezomib InjectionPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Dexamethasone tabletsPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- LucitanibPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Oral rucaparibPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Panobinostat CapsulesPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 2 · Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- RucaparibPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Sacituzumab govitecanPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- AbirateronePhase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- FarydakMultiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesPHASE2 · TERMINATED · started Jan 16, 2020ClinicalTrials.gov NCT04171700 · fetched Nov 12, 2026
- Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)PHASE1 · COMPLETED · started Dec 5, 2019ClinicalTrials.gov NCT04179396 · fetched Nov 12, 2026
- A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on PanobinostatCOMPLETED · started Nov 4, 2019ClinicalTrials.gov NCT04150289 · fetched Nov 12, 2026
- A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)PHASE2 · TERMINATED · started Aug 23, 2019ClinicalTrials.gov NCT03824704 · fetched Nov 12, 2026
- A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)PHASE1_PHASE2 · TERMINATED · started Jun 28, 2019ClinicalTrials.gov NCT03992131 · fetched Nov 12, 2026
- Rucaparib in Patients With Locally Advanced or Metastatic Urothelial CarcinomaPHASE2 · TERMINATED · started Jun 1, 2018ClinicalTrials.gov NCT03397394 · fetched Nov 12, 2026
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyPHASE3 · ACTIVE_NOT_RECRUITING · started May 14, 2018ClinicalTrials.gov NCT03522246 · fetched Nov 12, 2026
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyPHASE3 · COMPLETED · started Jun 13, 2017ClinicalTrials.gov NCT02975934 · fetched Nov 12, 2026
- ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsPHASE3 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT02855944 · fetched Nov 12, 2026
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyPHASE2 · COMPLETED · started Feb 15, 2017ClinicalTrials.gov NCT02952534 · fetched Nov 12, 2026
- Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple MyelomaPHASE2 · COMPLETED · started Apr 27, 2016ClinicalTrials.gov NCT02654990 · fetched Nov 12, 2026
- Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)PHASE3 · COMPLETED · started Apr 7, 2014ClinicalTrials.gov NCT01968213 · fetched Nov 12, 2026
- A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA MutationPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02042378 · fetched Nov 12, 2026
- A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)PHASE2 · COMPLETED · started Oct 30, 2013ClinicalTrials.gov NCT01891344 · fetched Nov 12, 2026
- A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)PHASE1_PHASE2 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01482715 · fetched Nov 12, 2026